NCT01389284 - Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Pain, Postoperative

Interventions

DRUG

Naproxen Sodium ER (BAYH6689)

660 mg Naproxen Sodium extended release tablet, orally administered once daily for 24 hours

DRUG

Naproxen Sodium IR (Aleve, BAYH6689)

220 mg Naproxen Sodium instant release tablet, orally administered 3 times daily (TID) for 24 hours

DRUG

Naproxen Sodium ER Placebo

Matching placebo of 660 mg Naproxen Sodium ER for 24 hours

DRUG

Naproxen Sodium IR Placebo

Matching placebo of 220 mg Naproxen Sodium IR (Aleve) for 24 hours

Trial Locations (1)

Austin